Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joshua A. Stanton"'
Autor:
Junzhi Yang, Robert D. Betterton, Erica I. Williams, Joshua A. Stanton, Elizabeth S. Reddell, Chidinma E. Ogbonnaya, Emma Dorn, Thomas P. Davis, Jeffrey J. Lochhead, Patrick T. Ronaldson
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 949 (2022)
The consumption of acetaminophen (APAP) can induce neurological changes in human subjects; however, effects of APAP on blood–brain barrier (BBB) integrity are unknown. BBB changes by APAP can have profound consequences for brain delivery of co-admi
Externí odkaz:
https://doaj.org/article/3bb6e64239064ecc9e872abbd242f14f
Autor:
Erica I Williams, Robert Betterton, Joshua A Stanton, Jeffrey J Lochhead, Thomas P Davis, Patrick T Ronaldson
Publikováno v:
Stroke. 54
Clinical development of new drugs for ischemic stroke has been challenging. In contrast, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (i.e., statins) are routinely administered to stroke patients because they improve neurological outcom
Autor:
Joshua A. Stanton, Erica I. Williams, Robert D. Betterton, Thomas P. Davis, Patrick T. Ronaldson
Publikováno v:
Exp Neurol
Drug discovery and development for stroke is challenging as evidenced by few drugs that have advanced beyond a Phase III clinical trial. Memantine is a N-methyl-D-aspartate (NMDA) receptor antagonist that has been shown to be neuroprotective in vario
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::843b16248b4630917fa3074de498c326
https://europepmc.org/articles/PMC9620710/
https://europepmc.org/articles/PMC9620710/
Autor:
Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey L. Lochhead, Hrvoje Brzica, Joshua A Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P Davis, Patrick T. Ronaldson
Publikováno v:
Drug Metabolism and Disposition. :DMD-AR